Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital

R J Drew1, J F Turton, R L R Hill

  • 1Department of Microbiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Richard.drew@alderhey.nhs.uk

Insights

Carbapenem-resistant Enterobacteriaceae (CRE) are a growing threat in UK children's hospitals. Active surveillance is crucial for monitoring and controlling these infections, especially those with carbapenemases.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Paediatric Healthcare

Background:

  • Carbapenem-resistant Enterobacteriaceae (CRE) pose a significant and increasing global infection risk.
  • Limited data exist on the clinical impact and prevalence of CRE infections specifically within paediatric populations.
  • Understanding CRE epidemiology in children is vital for effective infection control.

Purpose of the Study:

  • To determine the prevalence of CRE in clinical and surveillance samples from a UK tertiary children's hospital.
  • To identify the resistance mechanisms employed by CRE isolates in this paediatric setting.
  • To characterize carbapenemase-producing strains using molecular typing.

Main Methods:

  • Retrospective analysis of clinical and surveillance specimens collected between September 2011 and August 2012.
  • Phenotypic and molecular methods were used to ascertain carbapenem resistance mechanisms.
  • Variable number tandem repeat (VNTR) profiling was employed for typing carbapenemase-producing isolates.

Main Results:

  • CRE were identified in 24 patients over a 12-month period.
  • The prevalence of CRE detected via rectal surveillance was 4.5% (19/421 patients).
  • Seven isolates harboured carbapenemases (three blaKPC, four blaNDM); 17 exhibited resistance via AmpC/ESBLs and impermeability.

Conclusions:

  • CRE, particularly carbapenemase-producers, represent an emerging infectious challenge in UK paediatric hospitals.
  • The findings underscore the need for robust active surveillance programs to manage and mitigate CRE spread in children.
  • Early detection and characterization of CRE are essential for guiding clinical management and public health interventions.
Abstract

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...